Pandey, T., Bhatti, S. A. (2025). Survival and safety of two year-fixed duration vs continuous immune checkpoint inhibitor therapy in advanced or metastatic NSCLC: A systematic review.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8584